UTAH MEDICAL PRODUCTS INC 10-K

ITEM 5 - MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market Information. UTMD's common stock trades on the NASDAQ Global Market (stock symbol: UTMD). The following table sets forth the high and low sales price information as reported by NASDAQ for the periods indicated: 2025 2024 High Low High Low 1st Quarter $ 65.56 $ 55.81 $ 85.76 $ 68.00 2nd Quarter 57.99 51.26 71.55 65.91 3rd Quarter 64.22 54.60 77.33 65.60 4th Quarter 64.46 53.66 68.99 60.39 Stockholders. The number of beneficial stockholders of UTMD’s common stock as of March 2, 2026 was at least 2,000. Dividends. The following sets forth cash dividends paid during the past two years: Record Date Payable Date Per Share Amount March 15, 2024 April 3, 2024 0.300 June 14, 2024 July 5, 2024 0.300 September 20, 2024 October 4, 2024 0.300 December 16, 2024 January 3, 2025 0.305 March 14, 2025 April 3, 2025 0.305 June 16, 2025 July 3, 2025 0.305 September 17, 2025 October 2, 2025 0.305 December 16, 2025 January 5, 2026 0.310 2024 total cash dividends paid per share $ 1.2000 2025 total cash dividends paid per share $ 1.2200 Issuer Purchases of Equity Securities. In 2024, UTMD purchased 301,961 shares of its common stock for $19,968 including commissions and fees (an average price of $66.13/ share). In 2025, UTMD purchased 148,935 shares of its common stock for $8,355 including commissions and fees (an average price of $56.10/ share.) 2025 Calendar Quarter Shares Repurchased Average Cost Per Share Total Cost [K] 1Q 2025 54,267 $ 59.35 $ 3,221 2Q 2025 64,988 53.67 3,488 3Q 2025 11,729 55.67 653 4Q 2025 17,951 55.35 993 Year Total 148,935 $ 56.101 $ 8,355 As a subsequent event, through March 23, 2026 UTMD purchased 1,196 additional shares of its common stock for $67 including commissions and fees (an average price of $55.88/ share). ITEM 6 - RESERVED 20